Researchers from Mount Sinai have found a potential new target for bladder cancer treatment, which could lead to personalized treatment options for patients.
Dr. Jun Zhu discusses the significance of these findings, and what they could mean for the treatment of those with aggressive bladder cancer.
Learn the top bladder cancer risk factors you should avoid. Plus, learn who's more at risk for this cancer—men or women?
Bonus!
Almost 80 Million Americans Have This Virus
Selected Podcast
EP 909B Breakthroughs in Bladder Cancer Treatment
Featuring:
Jun Zhu, PhD
Jun Zhu, PhD, is a professor in Department of Genetics and Genomic Sciences and a member of Institute of Genomics and Multiscale Biology. Dr. Zhu was trained in both computer science and biomedical science. His research focuses on methodology development for integrating diverse omics data (e.g. genetic, genomic, transcriptomic, proteomic data and etc.) into probabilistic graphic networks. His work has been supported by multiple NIH grants and his methods have been used to identify novel drug targets and elucidate complex human disease mechanisms, which have resulted in publications in top journals in Nature, Nature Genetics, and Cell and multiple patents.Dr. Zhu has extensive experiences working in both biotech and pharmaceutical companies (Amgen, Inc, and Rosetta/Merck & CO, Inc) and academia (Sage Bionetworks, Fred Hutchinson Cancer Research Center, and Icahn School of Medicine at Mount Sinai).
Tagged under